Browse Trials

➤

Find Breast Cancer Clinical Trials That Are Right For You

The clinical trials listed below are open in the U.S. for people with DCIS (stage 0), stage 1, stage 2, stage 3, or stage 4 (metastatic)
breast cancer. Clinical trials are available for people who are newly diagnosed with breast cancer, currently in treatment, experiencing
breast cancer recurrence, living with metastatic disease, as well as breast cancer survivors who have completed treatment.

Use the search box and filters to find a trial that’s right for you.

Currently viewing trials
(Last updated: September 16, 2026)

and or

Reset

Zip Code:

Narrow my choices:

Radius (miles): All U.S.

All U.S.

Early stage

Advanced

Treatment

Non-treatment

Phase I II III

Display Only New Trials

AKT

ALK

BARD1

BRCA1/2 (tumor)

BRIP1

CD205

CD70

CHEK2 or CHEK1

dMMR/MSI-H

ESR1

FGFR

HER2/ERBB2

HLA

MET or C-Met

NTRK

PALB2

PIK3CA or PI3K

PTEN

RAD51

RAF (including BRAF)

RAS (KRAS or NRAS)

ROS1

TP53

Click here to view online studies and trials that do not require site visits

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT03452774

Using Artificial Intelligence to Match Patients to Clinical Trials (SYNERGY-AI)

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Scientific Title

Purpose

To study if a computer that has been taught how to match people to clinical trials (artificial intelligence) can help increase enrollment in clinical trials.

Who is this for?

People with advanced (some stage III) or metastatic (stage IV) breast cancer who have already decided to enroll in a clinical trial. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">A clinical trial matching report based on your medical records that you can review with your doctor.</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This trial will use artificial intelligence and virtual tumor boards to help match people to clinical trials.</li> <li class="seamTextUnorderedListItem">The researchers will also create a registry to study the medical and financial effects of this program. </li> <li class="seamTextUnorderedListItem">This is an international trial that is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03452774' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://massivebio.com/' target='_blank'>Massive Bio Study Information Page</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: III

NCT ID: NCT06748222

Virtual Mindfulness Approaches for Women With Depression Who Are Survivors of Stage 0-III Breast Cancer

Harnessing E-Mindfulness Approaches for Living After Breast Cancer-HEAL-ABC Scientific Title

Purpose

To study if a digital mindfulness meditation-based program can improve the mental health and well-being of younger breast cancer survivors with depression.

Who is this for?

Women who were age 18 to 50 years old when diagnosed with stage 0 (DCIS), stage I, stage II, or stage III breast cancer, who have completed breast cancer treatment (except hormone therapy or trastuzumab if recommended) 6 months to 5 years ago, and have symptoms of depression. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 3 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mindfulness, live virtual sessions, 2-hour sessions weekly for 6 weeks</li> <li class="seamTextUnorderedListItem">Practice mindfulness techniques, 5-20 minutes daily</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mindfulness, virtual sessions by app</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 3: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Guided audio mindfulness meditations, virtual sessions by app</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mindfulness meditation programs provided in person are helpful for younger breast cancer survivors. This study will compare different digital approaches for mindfulness training to see which is the most effective.</li> <li class="seamTextUnorderedListItem">Mindfulness delivered live provides structured lessons and guided exercises in mindfulness as well as opportunities for reflection and group discussion.</li> <li class="seamTextUnorderedListItem">Mindfulness delivered by app provides sequential new content and exercises that build on previous sessions. Lessons and other materials are gradually unlocked as participants progress through the program.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06748222' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No in person visits required

PHASE: NA

NCT ID: NCT07059884

Home Based Exercise Program to Preserve Strength and Prevent Disability During Chemotherapy for People With Breast Cancer

Distance-Based Exercise to Preserve Function and Prevent Disability Scientific Title

Purpose

To find out whether a guided exercise program can be successfully delivered to people from their own homes through video (telehealth) sessions while they are receiving chemotherapy.

Who is this for?

People with stage I, stage II, or stage III breast cancer who are about to start, or have recently started, chemotherapy. You must be 18 to 64 years old and able to walk for 6 minutes, and you should not already be doing regular strength training or competitive sports. This trial is also enrolling people with other types of cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Supervised video (telehealth) sessions 2 times a week</li> <li class="seamTextUnorderedListItem">Aerobic exercise on your own for a total of about 50 minutes each week</li> <li class="seamTextUnorderedListItem">You will receive equipment to use at home, such as a stationary bike, workbook, gloves, and resistance bands</li> <li class="seamTextUnorderedListItem">You will wear an activity tracker (accelerometer) throughout the study</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Chemotherapy can cause side effects like fatigue and loss of strength that make it harder to work, care for family, and do everyday activities. This study looks at whether a home based exercise program can help prevent those side effects and make it easier to stay active during treatment.</li> <li class="seamTextUnorderedListItem">Regular exercise during cancer treatment may help protect strength and physical function and reduce side effects like fatigue, but starting an exercise routine can be hard during treatment. </li> <li class="seamTextUnorderedListItem">Researchers want to learn whether delivering the program virtually is a practical way to help people stay active in their own homes while going through chemotherapy.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07059884' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.hopkinsmedicine.org/kimmel-cancer-center/cancers-we-treat/breast-gynecologic-malignancies-group/treatment-and-services/exercise-and-breast-cancer' target='_blank'>Johns Hopkins: Exercise and Breast Cancer</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT03448926

Impact of DCISionRT Test on Treatment Decisions for Women with DCIS and LCIS

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy (PREDICT) Scientific Title

Purpose

To study the impact of the DCISionRT test on treatment decisions for people with DCIS or LCIS.

Who is this for?

Women 30-85 years old with stage 0 (DCIS or LCIS) breast cancer who were diagnosed in the last 4 months and are planning to receive or have received a lumpectomy. You must have received the DCISionRT test. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will provide access to the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health data</li> <li class="seamTextUnorderedListItem">Imaging data</li> <li class="seamTextUnorderedListItem">Tissue samples</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The DCISionRT test predicts the risk of recurrence over 10 years and the benefit from radiation therapy.</li> <li class="seamTextUnorderedListItem">Your doctor will complete surveys before and after receiving the DCISionRT test. The surveys will study how the DCISionRT test results were used to make treatment decisions.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03448926' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://preludedx.com/patients/' target='_blank'>PreludeDx: DCISionRT</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT07208084

Virtual Intervention to Improve the Well-Being of Black Women With Stage 0-IV Breast Cancer

Project SOAR Awakenings: Randomized Controlled Trial for Black American Women Diagnosed With Breast Cancer Scientific Title

Purpose

To promote well-being and decrease depression and fatigue.

Who is this for?

Black women with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Project SOAR Gatherings, virtual, 1.5- to 2-hour discussions, weekly for 1 month</li> <li class="seamTextUnorderedListItem">Questionnaires, virtual, 3 times within 3 months</li> </ul> Group 2: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive materials by mail for use on your own</li> <li class="seamTextUnorderedListItem">Questionnaires, virtual, 3 times within 3 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Project SOAR sessions are based on books and articles that participants will receive. The sessions aim to help Black women accept their emotions, care for themselves, accept help from others, and manage stress.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07208084' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT02253251

Studying the Relationship Between Inherited KRAS Mutations and Breast Cancer Risk

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment Scientific Title

Purpose

To study the relationship between the KRAS mutation and cancer risk.

Who is this for?

People with stage I, stage II, stage III, and stage IV (metastatic) breast cancer, or people with a family history of breast cancer. You must also have endometriosis or an autoimmune condition. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will provide the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Saliva sample to test for the KRAS mutation</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">An inherited KRAS genetic mutation may increase a person's risk of developing breast or other types of cancer.</li> <li class="seamTextUnorderedListItem">This study will follow participants for 10 years. </li> <li class="seamTextUnorderedListItem">The researchers will also look at the effect that different lifestyle factors have on cancer risk. </li> <li class="seamTextUnorderedListItem">Participants will be able to get their KRAS mutation test results after submitting their sample at a discounted cost ($295).</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02253251' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://miradx.com/test/kras-variant/' target='_blank'>MiraKind Research Company: KRAS-Variant</a> </li><li class='seamTextUnorderedListItem'><a href='http://mirakind.org/study-eligibility-questionnaire/' target='_blank'>Research Company: Eligibility Survey</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT07076147

Questionnaire and Medical Records Review for Breast Cancer Screening as Recommended for Women at Moderate Risk for Breast Cancer

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer Scientific Title

Purpose

To assess breast cancer screening as recommended for women at moderately increased risk for developing breast cancer and to determine factors that promote or prevent screening.

Who is this for?

Women, age 30-75 years old, with a mutation in the genes ATM, CHEK2, BARD1, RAD51C, or RAD51D, or a lifetime breast cancer risk estimate between 20% and 40% according to the Tyrer-Cuzick V8.0B empiric risk model. You must not have breast cancer or have received a mastectomy. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaire</li> <li class="seamTextUnorderedListItem">Review of your medical records</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Breast cancer risk can be estimated by genetic mutation status and models that use responses to questions about personal and family health.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07076147' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: II

NCT ID: NCT06728579

Group Therapy to Manage Joint Pain From Hormone Therapy for Women with Stage I-III HR+ Breast Cancer

Enhanced Pain Coping in Cancer (EPIC) Scientific Title

Purpose

To study if group therapy can help breast cancer survivors manage joint pain caused by aromatase inhibitors.

Who is this for?

Women with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+) breast cancer who completed treatment at least 1 month ago. You must be receiving letrozole (Femara®), anastrozole (Arimidex®), or exemestane (Aromasin®) aromatase inhibitor and be planning to continue for at least 1 year. You must have joint pain. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Group therapy that includes mindfulness and other coping strategies, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Practice learned skills, at home, 15 minutes every day for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Group therapy that includes discussion on chronic pain and cancer survivorship, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Write in a journal, at home, 15 minutes every day for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Joint pain is common in people taking aromatase inhibitors. This pain can make some people decide to stop taking their medication. </li> <li class="seamTextUnorderedListItem">This study will look at the effects of 2 different types of group therapy on your cancer-related symptoms (such as pain, fatigue, and anxiety), your ability to continue taking aromatase inhibitors on a regular schedule, and your quality of life.</li> <li class="seamTextUnorderedListItem">All sessions in Group 1 and Group 2 are 2 hours each.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06728579' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: I

NCT ID: NCT07055854

Mindfulness Program to Promote Sexual Health after Breast Cancer

Virtual Mindful After Cancer Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors Scientific Title

Purpose

To study the effects of a mindfulness-based program and how it may help improve quality of life and sexual health in women with breast cancer.

Who is this for?

Women with stage I or stage II or stage III or stage IV (metastatic) breast cancer who were diagnosed at least 6 months ago, and have at least one concern related to sexual health or body image. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This study is testing a virtual program called Mindful After Cancer (MAC). The program is designed to help people with breast (and gynecologic) cancer manage concerns about sexual health and body image after treatment.</li> <li class="seamTextUnorderedListItem">Researchers with test how well the program can help in areas such as: sexual well-being and satisfaction, body image, emotional health (including anxiety and mood), mindfulness, self-confidence in managing health, and overall quality of life.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07055854' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.lbbc.org/about-breast-cancer/wellness-body-image/how-breast-cancer-impacts-your-body-image' target='_blank'>Living Beyond Breast Cancer: Body Image and Breast Cancer</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT04494945

Genetic Testing and Counseling to Identify People at Risk for Inherited Breast Cancer

Approaches to Identify and Care for Individuals With Inherited Cancer Syndromes Scientific Title

Purpose

To study the safety and effectiveness of offering genetic testing for inherited cancer syndromes to a broader population, rather than limiting testing only to people with strong family histories.

Who is this for?

People with or without a cancer diagnosis who are interested in genetic testing for inherited cancer risk. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be asked to do the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Provide a saliva sample</li> <li class="seamTextUnorderedListItem">Genetic counseling if your test results are positive</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Inherited cancer means having a higher cancer risk because of genes you are born with that run in your family.</li> <li class="seamTextUnorderedListItem">The study explores ways to identify people with inherited cancer risk and make sure they get the right care and follow‑up.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer, not just breast cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04494945' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.org/cancer/risk-prevention/genetics/family-cancer-syndromes/hboc-hereditary-breast-and-ovarian-cancer-syndrome.html' target='_blank'>American Cancer Society: Hereditary Breast and Ovarian Cancer Syndrome</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT04916990

Support Improving Treatment Completion for People in Rural Counties with Stage I-III Breast Cancer

Improving the Timeliness and Quality of Care for Rural Patients With Solid Tumors Scientific Title

Purpose

To study if the CARES intervention improves the time to start and complete treatment for people living in rural counties.

Who is this for?

People with stage I, stage II, or stage III breast cancer who live in a rural county and are planning to receive treatment at University of Colorado Health System. You must have no insurance or not enough insurance. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive CARES navigation and counseling, virtually or in person, up to 20 times within 6 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive list of resources</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The CARES (Cancer Advocacy, Resources, Education and Support) intervention includes up to 10 navigation and 10 counseling sessions provided by oncology nurses and counselors. </li> <li class="seamTextUnorderedListItem">CARES sessions will be scheduled during key treatment transition points.</li> <li class="seamTextUnorderedListItem">This study is also enrolling people with other types of cancer.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04916990' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT07029490

Chabot for Follow-up After a Mammogram for Healthy Women

Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study Scientific Title

Purpose

To study a digital tool called a chatbot that provides education about mammograms on a tablet, computer, or phone.

Who is this for?

Healthy women who have received a screening mammogram with the University of Utah and who speak English or Spanish. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care follow-up</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> Group 2: Chatbot <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Follow-up, by chatbot</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Chatbots are used in various healthcare situations and can be easily accessed with a smartphone, tablet, or computer. Chatbots have advantages for sending messages, including providing interactive education and information, providing information in small segments, and allowing a person to choose how much information they receive at a time. </li> <li class="seamTextUnorderedListItem">How useful chatbots are for follow-up after a mammogram is unknown.</li> <li class="seamTextUnorderedListItem">In this study, the chatbot will be used after a mammogram for follow-up, to answer patient questions, and to provide information.</li> <li class="seamTextUnorderedListItem">Some participants will be asked to join a focus group.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07029490' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06938555

Fasting at Night to Improve Cognition After Chemotherapy for People with Stage I-IV Breast Cancer

The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors (RESTORE) Scientific Title

Purpose

To study how fasting at night affects health, quality of life, and cognitive ability.

Who is this for?

Women with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who completed chemotherapy at least 3 months ago and who are having cognitive (thinking) problems. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fast at night, 6 nights every week for 2 months</li> <li class="seamTextUnorderedListItem">Health education videos, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 2 months</li> <li class="seamTextUnorderedListItem">Surveys, 2 times in 2 months</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health education videos, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 2 months</li> <li class="seamTextUnorderedListItem">Surveys, 2 times in 2 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">When you are fasting, you are still allowed to drink water, coffee, and tea.</li> <li class="seamTextUnorderedListItem">Cognitive problems are problems with thinking (cognition).</li> <li class="seamTextUnorderedListItem">This trial's enrollment will be racially diverse (at least 50% of participants will be Black, Hispanic, and/or Native American).</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06938555' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: II

NCT ID: NCT05676255

Online Meditation to Reduce Anxiety and Depression After Treatment for Women with Stage I-III Breast Cancer

The SUPORT Project: Leveraging Social Connection by Including Informal Caregivers in an Internet Video Conference-based Compassion Meditation Intervention to Reduce Psychological Distress in Breast Cancer Survivors Scientific Title

Purpose

To study if meditation with or without caregivers will reduce depression and anxiety in breast cancer survivors.

Who is this for?

Women with stage I, stage II, or stage III breast cancer who completed treatment between 3 months and 5 years ago. You may still be receiving hormone therapy or trastuzumab (Herceptin®). You must have a partner or caregiver who lives with you and is willing to participate. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 3 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Meditation sessions without your partner, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Meditation sessions with your partner, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 3: Health Education <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health education sessions with your partner, virtual, weekly for 2 months</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Many breast cancer survivors (around 70%) experience depression and/or anxiety after finishing cancer treatments.</li> <li class="seamTextUnorderedListItem">Meditation may reduce feelings of anxiety and depression.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05676255' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: II

NCT ID: NCT07001241

Remote Exercise Program to Reduce Fatigue for Stage 0-III Breast Cancer Survivors Living in Rural Areas

Effects of a Telehealth Exercise Program for Rural Cancer Survivors With Cancer-related Fatigue Including Integrated Longitudinal Assessments of Objective Physical Function and Fatty Acid Oxidation Scientific Title

Purpose

To study whether a virtual exercise program reduces cancer-related fatigue.

Who is this for?

People with stage 0 (DCIS), stage I, stage II, or stage III breast cancer who completed treatment that included hormone therapy, radiation, chemotherapy, and/or immunotherapy within the last 5 years. You may currently be receiving hormone therapy. You must live in a rural area and have moderate or worse fatigue. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, virtual, for 3 months</li> <li class="seamTextUnorderedListItem">Surveys, 2 times per month</li> <li class="seamTextUnorderedListItem">Blood samples, by self collection, 2 times per month</li> </ul> Group 2: Waitlist Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Surveys, 2 times per month</li> <li class="seamTextUnorderedListItem">Blood samples, by self collection, 2 times per month</li> </ul> followed by (3 months later): <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise program, virtual, for 3 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Exercise may help improve cancer-related fatigue.</li> <li class="seamTextUnorderedListItem">The exercise program in this study includes virtual exercise sessions with cancer exercise specialists, additional exercise programming delivered by an app, and regular symptom monitoring by emailed surveys.</li> <li class="seamTextUnorderedListItem">The study includes 2 optional visits to the study site for laboratory-based exercise assessment before and after the program.</li> <li class="seamTextUnorderedListItem">This study is also enrolling people with prostate cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07001241' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06085313

Online Pain and Depression Support Program for Asian Women with Stage I-IV Breast Cancer

Cancer Pain Management: A Technology-Based Intervention for Asian American Breast Cancer Survivors (CAI) Scientific Title

Purpose

To study if an online pain and depression management program can support Asian women with breast cancer.

Who is this for?

Chinese, Korean, or Japanese women who were diagnosed with breast cancer in the past and are experiencing pain and depression. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: CAI (Web App Based, Individualized Coaching and Support Program for Cancer Pain) <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Personalized information and support program, online</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: CAPA (Web App Based Information and Coaching/Support Program for Cancer Pain Management) <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General information and support program, online</li> <li class="seamTextUnorderedListItem">Fitbit</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem"> The pain and depression management program provides web-based information, coaching, and support that is culturally tailored to Asian American women with breast cancer.</li> <li class="seamTextUnorderedListItem">This trial is also available in Mandarin (simplified or traditional), Korean, and Japanese.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06085313' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT05654246

Susan G. Komen ShareForCures Research Registry

ShareForCures: Susan G. Komen's People-powered, Data-driven Breast Cancer Research Registry Scientific Title

Purpose

To create a research registry of data from people with breast cancer, including minority and marginalized people, to ensure data is as diverse as the people touched by the disease.

Who is this for?

People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will provide the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Tissue samples</li> <li class="seamTextUnorderedListItem">Blood samples</li> <li class="seamTextUnorderedListItem">Saliva samples</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Researchers will have a better understanding of breast cancer and everyone can potentially benefit from scientific advances and improvements in care.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05654246' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.komen.org/shareforcures/' target='_blank'>Susan G. Komen: ShareForCures</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cdc.gov/cancer/npcr/value/registries.htm' target='_blank'>Centers for Disease Control and Prevention: How Cancer Registries Work</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: II

NCT ID: NCT06377696

Care and Monitoring at Home for People with Brain Metastasis

Neuro-Oncology Anywhere: Deploying Mayo Clinic's Remote Cognitive Assessment Battery and Wearable Device Monitoring Platform While Assessing the Impact of Metformin on Cognition and Quality of Life in Patients With History of Cranial Radiation Scientific Title

Purpose

To study if giving metformin and monitoring can be done at home for people receiving brain radiation or who have previously had brain radiation.

Who is this for?

People with metastatic (stage IV) breast cancer that has spread to the brain (brain metastasis). You must be planning to receive brain radiation or completed brain radiation within the last 3 years. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Metformin, by mouth, daily, 1 year</li> <li class="seamTextUnorderedListItem">FitBit wearable device</li> <li class="seamTextUnorderedListItem">Cognitive tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li> </ul> Group 2: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard of care treatment, 1 year</li> <li class="seamTextUnorderedListItem">FitBit wearable device</li> <li class="seamTextUnorderedListItem">Cognitive tests</li> <li class="seamTextUnorderedListItem">Questionnaires</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Brain radiation can result in significant negative effects on cognition (the ability to clearly think, learn, and remember).</li> <li class="seamTextUnorderedListItem">Cognitive tests study your cognition, which is your ability to think.</li> <li class="seamTextUnorderedListItem">Metformin is a drug approved to treat type 2 diabetes (a condition in which the body cannot control the level of sugar in the blood).</li> <li class="seamTextUnorderedListItem">Metformin may also be used to treat cancer and improve your cognition (ability to think) and quality of life.</li> <li class="seamTextUnorderedListItem">In this study, a FitBit wearable device will be used to monitor and detect seizures.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06377696' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://mbcbrainmets.org/' target='_blank'>MBCBrainMets.org</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mayo.edu/research/clinical-trials/cls-20567690' target='_blank'>Mayo Clinic: Trial Information Page</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT04169542

Questionnaires to Understand Financial Impacts of Surgery and COVID-19 for Women Receiving a Mastectomy

Financial Toxicity in Patients Undergoing Breast Reconstruction: The Impact of Out of Pocket Costs, Lost Wages and Unemployment Scientific Title

Purpose

To collect information about the financial impact of breast cancer surgery and to learn if the COVID-19 pandemic affects patient costs of breast reconstruction.

Who is this for?

Women with stage 0 (DCIS), stage I, stage II, or stage III breast cancer or women at high risk for breast cancer who are planning to receive a mastectomy and breast reconstruction at MD Anderson Cancer Center. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Questionnaires, virtual, 4 times within 2 years</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">People receiving breast reconstruction after a mastectomy are at high risk for financial toxicity (harmful effects of high health care cost on well-being).</li> <li class="seamTextUnorderedListItem">The COVID-19 pandemic may affect these costs.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04169542' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://metastatictrialtalk.org/resources-support/find-financial-support-cancer/' target='_blank'>Metastatic Trial Talk: Where to Find Financial Support</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT04988009

Phone Survey to Improve Telemedicine Visits for Brain Metastasis

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology Scientific Title

Purpose

To compare opinions of telemedicine (virtual) visits and in-person visits to improve telemedicine (virtual) visits.

Who is this for?

People with metastatic (stage IV) breast cancer that has spread to the brain (brain metastases) who had at least 2 visits at the MD Anderson Cancer Center Brain and Spine Center. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Survey, by phone</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">During the phone survey, you will be asked about your opinions on the quality of care you received at your telemedicine (virtual) or in-person visits.</li> <li class="seamTextUnorderedListItem">Telemedicine visits are also called virtual visits.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04988009' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://mbcbrainmets.org/' target='_blank'>MBCBrainMets.org</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT07227077

Virtual Reminders to Increase Physical Activity for People With Stage I-III Breast Cancer and Chronic Pain

An Adaptive Design for Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial Scientific Title

Purpose

To study the best time to deliver a message to increase physical activity and how often participants experience pain in the 24 hours after receiving a message to increase physical activity.

Who is this for?

People, 65 years and older, with stage I, stage II, or stage III breast cancer who have completed cancer treatment. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Messages to report pain, virtual, 4 times a day for 1 month</li> <li class="seamTextUnorderedListItem">Messages to increase physical activity, virtual, 4 times a day for 1 month</li> <li class="seamTextUnorderedListItem">Wear activity monitor, 1 month</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This trial is studying the best time to send a message to promote physical activity by cancer survivors who experience chronic pain.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07227077' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT05483283

Empowerment and Navigation Sessions for Latina Women Ages 30+ with Breast Cancer or a Family History of Breast/Ovarian Cancer

Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care Scientific Title

Purpose

To compare the impact of empowerment and navigation sessions with standard of care sessions on whether Latina women decide to receive genetic testing and/or genetic counseling.

Who is this for?

Latina women ages 30+ with stage I, stage II, stage III, or stage IV (metastatic) breast cancer or with a family history of breast or ovarian cancer. You must have one social determinant of health risk factor, such as: perceived financial struggles, transportation difficulties, exposure to violence, housing challenges, social isolation/challenges. You must not have received genetic testing or genetic counseling. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Empowerment and navigation sessions, by phone, 3 times within 3 weeks</li> <li class="seamTextUnorderedListItem">Personalized educational materials</li> </ul> Group 2: Standard of Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard of care sessions, by phone, 3 times within 3 weeks</li> <li class="seamTextUnorderedListItem">Personalized educational materials</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Empowerment and navigation sessions will discuss social determinants of heath, genetic risk factors, individual behavior change action plans, breast cancer screening, and diet and physical activity for breast cancer prevention.</li> <li class="seamTextUnorderedListItem">Standard of care sessions will discuss social determinants of heath, genetic risk factors, individual behavior change action plans, how to share breast cancer information, and testimonials and include role playing activities and group discussions.</li> <li class="seamTextUnorderedListItem">You can receive up to $100 for participation.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05483283' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/cancer-prevention-and-early-detection-facts-and-figures/making-the-case-for-health-equity.pdf' target='_blank'>American Cancer Society: Health Equity and Social Determinants of Health</a> </li><li class='seamTextUnorderedListItem'><a href='https://odphp.health.gov/healthypeople/priority-areas/social-determinants-health' target='_blank'>US Department of Health and Human Services: Social Determinants of Health</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT07218432

The TheraBionic P1 Device to Reduce Tumor Size Before Surgery for Women With Stage I-III HR+, HER2- Breast Cancer

A Window of Opportunity Pilot Study: TheraBionic P1 Device for Patients With Resectable Early-stage Breast Cancer in a Neoadjuvant Setting Scientific Title

Purpose

To study if the TheraBionic P1 device reduces the tumor size before surgery (neoadjuvant).

Who is this for?

Women with stage I, stage II, or stage III hormone receptor positive (ER+ and/or PR+), HER2 negative (HER2-) breast cancer who are planning to receive surgery as their first treatment for breast cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Use the TheraBionic P1 device, self administered, three 1-hour sessions per day for 2 weeks</li> <li class="seamTextUnorderedListItem">PET scan, 2 times within 2 weeks (optional)</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The TheraBionic P1 device creates an electromagnetic field that may reduce the tumor size before surgery. In this study, participants will use the device during the 2 weeks before surgery.</li> <li class="seamTextUnorderedListItem">The TheraBionic P1 Device is FDA approved to treat liver cancer. Its use in this trial is considered experimental.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07218432' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.karmanos.org/karmanos/therabionic-p1-device#:~:text=Due%20to%20the%20device's%20low%20emitting%20power%2C,of%20electromagnetic%20fields%20in%20the%20patient's%20body.' target='_blank'>Karmanos Cancer Institute: TheraBionic P1 Device</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06855654

Coaching Program to Reduce Stress and Promote Resilience for People with Metastatic Breast Cancer

Promoting Resilience in Stress Management for Metastatic Breast Cancer (PRISM-MBC PRISMMBC) Scientific Title

Purpose

To study the ability of the PRISM program to reduce stress and improve resilience for people with metastatic breast cancer.

Who is this for?

People with stage IV (metastatic) breast cancer who were diagnosed with metastatic disease in the last 6 months. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Promoting Resilience in Women with Breast Cancer (PRISM) program, virtual, 4 sessions in 1-2 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The Promoting Resilience in Women with Breast Cancer (PRISM) program helps improve 4 areas of resilience: stress management, goal setting, cognitive reframing, and meaning-making.</li> <li class="seamTextUnorderedListItem">This study will compare the resilience of Black women to non-Black women.</li> <li class="seamTextUnorderedListItem">It also includes an optional family session.</li> <li class="seamTextUnorderedListItem">Each session is 30-60 minutes every 1-2 weeks.</li> <li class="seamTextUnorderedListItem">Black women with MBC have worse outcomes than white women with MBC because of social determinants of health (SDOH).</li> <li class="seamTextUnorderedListItem">Social determinants of health (SDOH) describe non-medical factors that influence your health, such as race, gender identity, education, occupation, transportation, food and health access, medication affordability, safety at home, housing, and financial stability.</li> <li class="seamTextUnorderedListItem">Reducing stress and improving resilience during MBC treatment may improve quality of life and even improve disease outcomes.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06855654' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No in person visits required

PHASE: II

NCT ID: NCT07443943

Resistant Potato Starch Dietary Supplement for Reducing Joint and Muscle Pain in People Taking an Aromatase Inhibitor for Breast Cancer

Phase 2 Study of Aromatase Inhibitor-Associated Musculoskeletal Symptom Prevention With Resistant Potato Starch (AIMSS-RPS) Scientific Title

Purpose

To study whether a dietary supplement called resistant potato starch can help reduce joint and muscle pain (such as joint stiffness and achiness) that is commonly caused by aromatase inhibitor therapy.

Who is this for?

People with stage 0 (DCIS), stage I, stage II, or stage III breast cancer, or people at high risk of developing breast cancer who are planning to start aromatase inhibitor therapy and expect to take it for at least 6 months, have mild to moderate joint pain (rated 0–6 on a 0–10 scale) in the week before enrolling. You must not have previously taken an aromatase inhibitor (except as part of fertility treatment), and you must be receiving care at the University of Michigan Rogel Cancer Center. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Resistant potato starch (RPS), by mouth, once daily, for 6 months</li> <li class="seamTextUnorderedListItem">Treatment diary to track your dose</li> <li class="seamTextUnorderedListItem">Questionnaires </li> <li class="seamTextUnorderedListItem">Provide stool samples, 2 times</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aromatase inhibitors are hormonal therapy medicines used to treat or help prevent breast cancer.</li> <li class="seamTextUnorderedListItem">Many people who take aromatase inhibitors develop joint pain, stiffness, and discomfort, a condition known as aromatase inhibitor-associated musculoskeletal symptoms (AIMSS). Research suggests that lower levels of beneficial gut bacteria may be linked to the development of these joint and muscle symptoms. </li> <li class="seamTextUnorderedListItem">Resistant potato starch is a plant-based carbohydrate that may help promote the growth of beneficial gut bacteria, which may in turn help reduce joint pain and stiffness in people taking aromatase inhibitor therapy.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07443943' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment-side-effects/pain/bone-joint' target='_blank'>Breastcancer.org: Joint and Bone Pain From Breast Cancer Treatment</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06915168

Virtual Tool to Help Make Chemotherapy Decisions for People with Stage I-IV Breast Cancer

CIPN Decision Aid to Improve Neurotoxic Chemotherapy Decision Making Scientific Title

Purpose

To see if a virtual tool that informs people about chemotherapy-induced peripheral neuropathy (CIPN) helps people make decisions about chemotherapy.

Who is this for?

People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who are receiving paclitaxel (Taxol®), nab-paclitaxel (Abraxane®), or docetaxel (Taxotere) chemotherapy and are experiencing peripheral neuropathy (nerve pain, discomfort, sensation changes, or weakness). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Virtual chemotherapy decision tool</li> <li class="seamTextUnorderedListItem">Surveys</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Neuropathy is pain, discomfort, sensation changes, and weakness from nerve damage.</li> <li class="seamTextUnorderedListItem">Chemotherapy-induced peripheral neuropathy (CIPN) is neuropathy in your hands and feet as a side effect of chemotherapy.</li> <li class="seamTextUnorderedListItem">Around half of people who develop CIPN still have it 3 years later.</li> <li class="seamTextUnorderedListItem">A virtual decision tool that provides information about permanent CIPN and prepares patients for a discussion with their doctor may lead to improvements in treatment decision-making.</li> <li class="seamTextUnorderedListItem">This trial is enrolling virtually and does not require any in person visits.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06915168' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06582615

Healthy Eating and Nutrition Counseling to Improve Cognition During Chemotherapy for Women with Stage II-III Triple Negative Breast Cancer

Food for Thought - Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Triple Negative Breast Cancer (MIND-TNBC) Scientific Title

Purpose

To study if the MIND eating plan can improve memory and mental function, fatigue, sleep quality, anxiety, and depression.

Who is this for?

Women 40-65 years old with stage II or stage III triple negative (ER-, PR-, HER2-) breast cancer who are receiving (within the past 6 months) or planning to receive chemotherapy before surgery (neoadjuvant). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MIND counseling sessions, virtual, weekly for 1 month, then every 2 weeks for 2 months</li> <li class="seamTextUnorderedListItem">Personalized eating plan, 3 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 6 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General health sessions, virtual, weekly for 1 month, then every 2 weeks for 2 months</li> <li class="seamTextUnorderedListItem">Wear a FitBit</li> <li class="seamTextUnorderedListItem">Cognitive tests, 2 times in 6 months</li> <li class="seamTextUnorderedListItem">Surveys</li> </ul> followed 6 months later by: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MIND counseling sessions, virtual, weekly for 1 month, then every 2 weeks for 2 months</li> <li class="seamTextUnorderedListItem">Personalized eating plan, 3 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Cancer treatment can lead to cognition (ability to think) problems and low quality of life.</li> <li class="seamTextUnorderedListItem">The Neurodegenerative Delay (MIND) eating plan is high in anti-inflammatory nutrients (omega-3, carotenoids, B vitamins, etc.) and limits foods that are not healthy for the brain (butter, cheese, red meat, fried foods, sugar, etc.).</li> <li class="seamTextUnorderedListItem">The MIND eating plan may help improve brain function during cancer treatment.</li> <li class="seamTextUnorderedListItem">In this trial, you will be sent some of the main foods in the MIND eating plan.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06582615' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://health.osu.edu/wellness/exercise-and-nutrition/the-mind-diet' target='_blank'>Ohio State University: The MIND Diet and Brain Health</a> </li></ul>

No Travel Required

VISITS: No Visits Required, up to 5 months

PHASE: NA

NCT ID: NCT07320664

Alcohol Awareness Messaging to Reduce Breast Cancer Risk in Young Women

Alcohol Counter Marketing as a Breast Cancer Prevention Strategy in Young Women Scientific Title

Purpose

To test whether targeted digital messages about the link between alcohol and breast cancer risk can help reduce alcohol use and increase awareness of that risk in young women.

Who is this for?

Women who do not have breast cancer, aged 18–25 who have had at least one alcoholic drink in the past 30 days and currently live in Ohio, Michigan, Illinois, Wisconsin, or New Jersey. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Researchers want to know if digital messages, created with input from young women, can reduce how much alcohol young women drink, increase awareness that drinking alcohol raises breast cancer risk, and improve beliefs about the ability to reduce that risk by drinking less</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07320664' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.bcrf.org/about-breast-cancer/alcohol-breast-cancer-risk/' target='_blank'>Breast Cancer Research Foundation: Alcohol and Breast Cancer Risk</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT07009093

Mobile App to Reduce Emotional Distress in Women Under Age 45 With Breast Cancer

Utility of a Mobile Application for Young Women With Breast Cancer Scientific Title

Purpose

To study the effects of using a mobile health application (the Mighty Pro app) to understand if it can help reduce cancer‑related emotional distress.

Who is this for?

Women, under age 45, with stage0 (DCIS) or stage I or stage II or stage III or stage IV breast cancer, experiencing moderate to high cancer‑related distress, and who are receiving care at Wake Forest Baptist Cancer Center. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be assigned to 1 of 2 groups: Group 1: Intervention <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Use of Mighty Pro mobile application, for 1 year</li> </ul> Group 2: Standard of Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard of care</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This study is looking at whether using a mobile health application can help reduce cancer‑related distress in young women with breast cancer.</li> <li class="seamTextUnorderedListItem">The Mighty Pro app includes educational content and social connection for people with breast cancer.</li> <li class="seamTextUnorderedListItem">This trial does not require any in‑person visits and participation takes place using a mobile device over a 12‑month period.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07009093' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.lbbc.org/about-breast-cancer/emotional-health/managing-emotional-side-effects?utm_source=ppc&utm_medium=search&utm_campaign=in-treatment&utm_id=journey&gad_source=1&gad_campaignid=22665797719&gbraid=0AAAAAoX38tAgGRpQ7upZLxlLw_64Mdgcb&gclid=EAI' target='_blank'>Living Beyond Breast Cancer: Managing emotional side effects</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT05655494

Online Portal to Educate and Refer Racially Diverse People to Clinical Trials

Precision Clinical Trial Recruitment to Promote Cancer Health Equity Across Florida Scientific Title

Purpose

To study the tailored ALEX (Agent Leveraging Empathy for eXams) Research Portal to navigate Black and Hispanic adults with cancer and their family members through referral to cancer clinical trials.

Who is this for?

People who are Black, African American, Hispanic, and/or Latinx. People with cancer and their family members may enroll in this trial. You must live in Florida. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">ALEX (Agent Leveraging Empathy for eXams) portal</li> </ul> Group 2: Standard of Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard of care portal</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Racial and ethnic minorities are underrepresented in cancer clinical trials.</li> <li class="seamTextUnorderedListItem">The ALEX (Agent Leveraging Empathy for eXams) Research Portal uses culturally responsive, virtual community health educators to reach diverse populations.</li> <li class="seamTextUnorderedListItem">Clinicians can utilize the ALEX portal to refer patients to trials. Community health educators can use the portal to help provide information to patients and schedule follow-ups. Patients and family members can use the portal to access key information and make referrals.</li> <li class="seamTextUnorderedListItem">The standard of care portal provides participants with access to existing online cancer clinical trial resources in one location.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05655494' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://metastatictrialtalk.org/inside-clinical-trials/diversity-in-clinical-trials-2/' target='_blank'>Steps Toward Expanding Eligibility Criteria to Increase Diversity in Clinical Trials</a> </li><li class='seamTextUnorderedListItem'><a href='https://metastatictrialtalk.org/inside-clinical-trials/diversity-in-clinical-trials/' target='_blank'>The Lack of Diversity in Clinical Trials</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06371768

Virtual Program to Increase Symptom Management and Health Care Visits for Young Adults with Stage I-III Breast Cancer

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors (AYA STEPS) Scientific Title

Purpose

To study a digital health program called AYA STEPS, which is designed to help adolescent and young adult (AYA) cancer survivors manage symptoms and receive recommended follow-up care.

Who is this for?

People, age 18-39 years, with stage I, stage II, or stage III breast cancer who have completed all cancer treatments (except hormone therapy if recommended) within the last 3 months and whose diagnosis was 1-5 years ago. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be randomly assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">AYA STEPS, virtual, 6 sessions within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 3 months</li> </ul> Group 2: Control <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education, virtual, 6 sessions within 3 months</li> <li class="seamTextUnorderedListItem">Questionnaires, 4 times within 3 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">AYA STEPS provides cognitive-behavioral and related skills to improve participants' ability to self-manage symptoms and increase health care visits.</li> <li class="seamTextUnorderedListItem">This trial is enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06371768' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No in person visits required

PHASE: NA

NCT ID: NCT07300995

Coping Program for Women with Stage I to IV Breast Cancer with Pain

Brief Pain Coping Skills Training for Older Women With Breast Cancer and Pain: An Efficacy-Effectiveness Randomized Controlled Trial Scientific Title

Purpose

This trial is looking at whether a telehealth pain coping program can help lower pain and improve quality of life for women being treated for breast cancer. The program, called Pain Coping Skills Training, teaches practical skills for managing pain through one counseling session followed by short weekly support calls.

Who is this for?

Women age 55 or older with stage I, stage II, stage III, or stage IV breast cancer who have ongoing pain. You must have reported pain on at least 10 days in the past month, with a worst pain rating of 4 or higher on a scale of 0 to 10 in the past week. You must be receiving cancer care at a Duke Cancer Network clinic. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be assigned to 1 of 2 groups. Group 1: Pain Coping Skills Training <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">One telehealth session with a study nurse, about 50 minutes, followed by 5 weekly 15 minute phone calls </li> <li class="seamTextUnorderedListItem">2 follow up surveys, at 10 weeks and 15 weeks</li> </ul> Group 2: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">You will continue your regular care </li> <li class="seamTextUnorderedListItem">2 follow up surveys, at 10 weeks and 15 weeks</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This trial is studying Pain Coping Skills Training, a behavioral program that teaches skills for managing pain, such as relaxation and ways to change thoughts and behaviors linked to pain. </li> <li class="seamTextUnorderedListItem">Researchers want to learn whether this telehealth based program can lower pain severity, reduce how much pain interferes with daily life, and improve quality of life, compared with usual care.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07300995' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment-side-effects/pain/managing-pain' target='_blank'>Breastcancer.org: Breast Cancer Pain Relief and Management</a> </li></ul>

No Travel Required

VISITS: Online surveys

PHASE: NA

NCT ID: NCT02333604

CSC Online Survey: The Cancer Experience Registry

Cancer Experience Registry: An Online Initiative to Understand the Experiences of Those Impacted by a Cancer Diagnosis (CER) Scientific Title

Purpose

To learn more about the emotional and social experiences and needs of people affected by cancer.

Who is this for?

People diagnosed with DCIS, stage I, stage II, stage III, or metastatic (stage IV) breast cancer and people who provide care to individuals diagnosed with cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

Participation in this study involves the completion of an online questionnaire. The questionnaire may be accessed at the following link: <a href="http://www.cancersupportcommunity.org/MainMenu/ResearchTraining/Cancer-Experience-Registry.html" target="_blank">www.cancerexperienceregistry.org</a>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The researchers hope to use this information to improve the educational materials and the overall quality of care that cancer patients receive. </li> <li class="seamTextUnorderedListItem">This study is also enrolling people diagnosed with other types of cancer. </li> <li class="seamTextUnorderedListItem">The data collected from this study can be found <a href="https://www.cancersupportcommunity.org/RegistryIndexReport2017" target="_blank">here.</a></li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02333604' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancerexperienceregistry.org/' target='_blank'>Cancer Support Community Study Website: Cancer Experience Registry</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cancersupportcommunity.org/RegistryIndexReport2017' target='_blank'>Cancer Support Community: Cancer Experience Registry Index Report 2017</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.youtube.com/watch?v=SyyUYqyNaCc' target='_blank'>Cancer Support Community YouTube Channel: What is the Cancer Experience Registry?</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT05126290

Registry to Study the CTNNA1 Gene and Cancer Risk

CTNNA1 Familial Expansion (CAFÉ) Study Scientific Title

Purpose

To identify the cancer risks associated with inherited mutations and other changes in a gene called CTNNA1.

Who is this for?

People with mutations in the CTNNA1 gene, and people with family members who have mutations in the CTNNA1 gene. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will complete the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Online questionnaire about medical, genetic, and family history</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mutations and other changes in a gene called CTNNA1 may be associated with inherited cancers, including gastric cancer, breast cancer, and other cancers.</li> <li class="seamTextUnorderedListItem">Better understanding of the relationship between CTNNA1 variations and breast cancer will be important for cancer risk management of individuals with these variations and their family members.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05126290' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT07054723

Surveys on a Mobile Phone to Study Stress and Cognitive Abilities for Women With Stage 0-III Breast Cancer

Daily Stress Process and Daily Cognitive Performance Among Racially Diverse Breast Cancer Survivors: A Feasibility and Validation Study Scientific Title

Purpose

To study a mobile daily diary designed to measure daily stress and cognitive (thinking) function.

Who is this for?

Asian, Black, Latina, or white women, age 40 and older, with stage 0 (DCIS), stage I, stage II, or stage III breast cancer whose diagnosis was at least 5 years ago. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mobile phone</li> <li class="seamTextUnorderedListItem">Surveys, virtual, daily for 2 weeks</li> <li class="seamTextUnorderedListItem">Cognitive (thinking) tests, virtual, daily for 2 weeks</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The surveys ask about sleep, outlook, anticipated stress, positive experiences, and daily experiences (stressors, mood, and physical symptoms). </li> <li class="seamTextUnorderedListItem">The surveys are available in English, Spanish, or Chinese.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07054723' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06773897

Saliva Samples and Questionnaires to Study How Genes Affect Breast Cancer Risk

The Rutgers University Genetics Coordinating Center Breast Cancer Study Scientific Title

Purpose

To study how genes impact breast cancer risk.

Who is this for?

People with stage 0 (DCIS), stage I, stage II, stage III, or stage IV (metastatic) breast cancer, and people who have not been diagnosed with breast cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Provide saliva (spit) sample, by mail</li> <li class="seamTextUnorderedListItem">Questionnaires, online</li> <li class="seamTextUnorderedListItem">Access to your health records (optional)</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">By participating in this study, you will receive information about your genetic risk for free.</li> <li class="seamTextUnorderedListItem">Mutations in genes called BRCA1 and BRCA2 explain only about 25% of the genetic cause of breast cancer. </li> <li class="seamTextUnorderedListItem">Researchers are trying to learn more about the genetic cause of breast cancer, which will help researchers create new treatments and improve current treatment options.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06773897' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: Mobile or online surveys

PHASE: NA

NCT ID: NCT00000003

MBC Connect Patient Registry: Sharing MBC History, Experiences, and Quality of Life

MBC Connect -- Patient Powered. Research Driven Scientific Title

Purpose

To collect information about the experiences of people with metastatic breast cancer for researchers and clinicians and to provide personalized information to each participant.

Who is this for?

People with metastatic (stage IV) breast cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">You will be asked to fill out surveys about your breast cancer diagnosis, treatment history and quality of life.</li> <li class="seamTextUnorderedListItem">Based on information you enter, you will get personalized insights and alerts with MBC news, events, and clinical trial opportunities.</li> </ul> To join the registry, click here: <a href="https://www.mbcconnect.org/" target="_blank">www.mbcconnect.org/</a>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">MBC Connect is a free, web and mobile-friendly registry that collects information about the experiences of people with metastatic breast cancer. </li> <li class="seamTextUnorderedListItem">Joining the registry allows you to receive personalized information about MBC-related news, events, and clinical trial opportunities. </li> <li class="seamTextUnorderedListItem">Researchers and clinicians will be able to analyze information collected in the registry in research studies. </li> <li class="seamTextUnorderedListItem">MBC Connect is available in English and Spanish.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'><a href='https://www.mbcconnect.org/' target='_blank'>MBC Connect</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.mbcalliance.org/' target='_blank'>Metastatic Breast Cancer Alliance</a> </li></ul>

No Travel Required

VISITS: 3 virtual visits, within 6 months

PHASE: NA

NCT ID: NCT06927895

Educational Program to Improve Side Effects for People With HER2+ or HER2 Low Breast Cancer Receiving Targeted Therapy

Patient-Centered Care-Improving the Patient Experience in the Management of Adverse Events (AEs) Associated With Antibody Drug Conjugates (ADCs) Scientific Title

Purpose

To study whether educational programs can help improve how patients and clinicians recognize, discuss, and manage side effects from HER2 targeted antibody drug conjugates (ADC) treatments.

Who is this for?

People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer with HER2 positive (HER2+) or HER2 low breast cancer, who are currently receiving HER2 targeted antibody drug conjugates (ADCs), or about to start treatment with a HER2 targeted ADC. You must be receiving care at NYU Langone Health. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will receive the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Recorded educational videos </li> <li class="seamTextUnorderedListItem">Online surveys</li> <li class="seamTextUnorderedListItem">3 virtual visits, within 6 months</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">An antibody-drug conjugate (ADC) is a type of therapy that combines an antibody that targets cancer cells with a therapy that can kill cancer cells.</li> <li class="seamTextUnorderedListItem">Because the antibody only targets cancer cells, the ADC does not kill normal cells, making it less likely to cause side effects.</li> <li class="seamTextUnorderedListItem">This is an all‑virtual study focused on education and communication. There are no study drugs given.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06927895' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: Online forms, questionnaires, saliva sample by mail

PHASE: NA

NCT ID: NCT00000002

MBC Project: Collecting Information About Metastatic Breast Cancer To Further Research

The Metastatic Breast Cancer Project Scientific Title

Purpose

To accelerate research in treating, curing and preventing metastatic breast cancer.

Who is this for?

People with metastatic (stage IV) breast cancer. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

Your participation will include the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Complete a simple online form about yourself and your cancer</li> <li class="seamTextUnorderedListItem">Fill out an online consent form that gives your permission for the researchers to obtain copies of your medical records and some of your stored tumor tissue</li> <li class="seamTextUnorderedListItem">Provide a saliva sample and send back via U.S. mail </li> </ul> To learn more and/or to participate, click here: <a href="https://www.mbcproject.org/" target="_blank">https://www.mbcproject.org/</a>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The goal of the Metastatic Breast Cancer Project is to accelerate research in treating, curing and preventing metastatic breast cancer. </li> <li class="seamTextUnorderedListItem">If you take part in the project, you will fill out questionnaires, provide a saliva sample, and share a piece of your stored tumor tissue and copies of your medical records with the researchers. </li> <li class="seamTextUnorderedListItem">The researchers believe analyzing this data will help them learn more about metastatic breast cancer and make more research advances. </li> <li class="seamTextUnorderedListItem">The MBC Project was created by a coalition of researchers and breast cancer advocacy organizations.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'><a href='https://www.mbcproject.org/' target='_blank'>The Metastatic Breast Cancer Project</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT06507930

Understanding the Experience of People with Advanced Breast Cancer Receiving Hospice Care

The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients with Metastatic Breast Cancer Receiving Hospice Care Scientific Title

Purpose

To better understand the in-home hospice experience for people with advanced breast cancer and their caregivers.

Who is this for?

People with advanced (some stage III) or metastatic (stage IV) breast cancer who live in Massachusetts and are planning to receive hospice care at home. Caregivers are also eligible to participate. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Telehealth appointments, by Zoom or phone, weekly for 1 month</li> <li class="seamTextUnorderedListItem">Survey, by email or phone</li> </ul> Group 2: Usual Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care</li> <li class="seamTextUnorderedListItem">Survey, by email or phone</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Telehealth check-in appointments will be with your oncology care team (doctor, physician assistant, nurse practitioner, or hospice nurse) by Zoom or phone call.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT06507930' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT05225428

Genetic Testing Educational Video for People with Stage I-IV Breast Cancer

Video Education With Result Dependent dIsclosure Scientific Title

Purpose

To study if an educational video improves knowledge of genetic testing for inherited cancer risk and could be used as an alternative to genetic counseling before genetic testing.

Who is this for?

People with stage I, stage II, stage III, or stage IV (metastatic) breast cancer who have not received genetic testing. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be assigned to 1 of 2 groups: Group 1: Experimental <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Watch educational video about genetic testing for inherited cancer risk</li> <li class="seamTextUnorderedListItem">Complete interview, by video or telephone</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times in 3 weeks</li> </ul> Group 2: Standard of Care <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Receive genetic counseling</li> <li class="seamTextUnorderedListItem">Questionnaires, 2 times in 3 weeks</li></ul>
<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The video summarizes the core educational components of a genetic counseling visit.</li> <li class="seamTextUnorderedListItem">This trial is also available in Spanish.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT05225428' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.cdc.gov/genomics/gtesting/genetic_testing.htm' target='_blank'>Centers for Disease Control and Prevention: Genetic Testing</a> </li></ul>

No Travel Required

VISITS: No Visits Required, up to 3 months

PHASE: NA

NCT ID: NCT07553572

Artificial Intelligence (AI) Symptom Support App for People with Breast Cancer

Pilot Randomized Controlled Trial of a Remote Monitoring and Symptom Management Intervention (ASSIST) Among Patients Receiving Systemic Therapy Scientific Title

Purpose

To study the ability of an artificial intelligence (AI) phone app (ASSIST) to help manage symptoms during cancer treatment.

Who is this for?

People with stage I or stage II or stage III or stage 4 (metastatic) breast cancer who are about to start, or have recently started (within 4 weeks), systemic treatment (such as chemotherapy, targeted therapy, or immunotherapy). Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

<ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This study is looking at a smartphone-based AI application called ASSIST that helps monitor symptoms and provide support during cancer treatment. Researchers want to understand if patients can use the app regularly and if they find it helpful and easy to use, compared with standard care alone.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of cancer.</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07553572' target='_blank'>ClinicalTrials.gov</a> </li></ul>

No Travel Required

VISITS: No visits required

PHASE: NA

NCT ID: NCT07177820

Video‑Guided Acupuncture Imagery Treatment for Women With Chemotherapy‑Induced Peripheral Neuropathy

Video-Guided Acupuncture Imagery Treatment in Chemotherapy-induced Peripheral Neuropathy Scientific Title

Purpose

To study and learn more about the feasibility of using a virtual mind‑body approach called Video‑Guided Acupuncture Imagery Treatment (VGAIT), where patients are asked to watch acupuncture being performed and imagine receiving it.

Who is this for?

Women ages 18 to 80 with stage I, or stage II or stage III breast cancer ,who have completed taxane‑based chemotherapy and have ongoing chemotherapy‑induced peripheral neuropathy (CIPN) symptoms for more than 2 weeks. Full eligibility criteria

Contact research site

Share with my doctor

Share with my patient

Contact Research Sites

What's involved?
What's being studied?
How can I learn more?

You will be asked to do the following: <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Watch videos of acupuncture and imagine receiving the treatment, virtual, 16 sessions</li> <li class="seamTextUnorderedListItem">Complete questionnaires at the start of the study, at 4 weeks, and at 8 weeks</li> <li class="seamTextUnorderedListItem">Complete brief assessments after each session</li></ul>
<ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT07177820' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/complementary-therapy/types/acupuncture' target='_blank'>Breastcancertrials.org: Accupuncture</a> </li></ul>